
Allegro demonstrates safety profile of osteoarthritis hydrogel in data presentation at World Congress on Osteoporosis
Allegro’s microparticle hydrogel hydrocelin has the potential to be a first-in-class disease-modifying injectable treatment for osteoarthritis Preclinical study to be presented at WCO conference shows no pyrogenicity Pivotal clinical trial in …